Oxford-MEStar

Innovations

  • Develops enabling technologies for tissue engineering and stem cell therapy
  • Measure Bowel Health, the first and only digital at-home testing kit for the detection of invisible traces of blood in stool
  • 3D printing services such as OMEFlex™️ and PetAssist™️

Partnering Objectives

Company Story

Oxford MEStar Limited is a spin-out company from the Institute of Biomedical Engineering of Oxford University specializing in translational and regenerative medicine. The company is devoted to a) developing novel technologies; b) offering bioengineering solutions to their clients; and c) technology transfer between the UK and China.

In December 2013 Oxford MEStar received £1M investment and another £1.1M in July 2015 from the private sector, and was awarded funding to take part in a 36-month, € 6.84 Million project under the European Union Interreg 2 Seas initiative that will support development and streamlined integration of 3D printing technologies to enable advanced medical treatment and its widespread application.

Leave us your contact information so we can reach you for the Healthcare & Life Sciences companies networking sessions in London.

Register your interest

Leave us your contact information so we can reach you for the Environmental & Agricultural Tech companies networking sessions in London.

Register your interest

Leave us your contact information so we can reach you for the Smart Cities Digital Economy companies networking sessions in London.

Register your interest

Supported By